anti-viral drug
Mylan Pharma to launch remdesivir in India at Rs 4,800 per 100 mg vial
The drug will be launched under the brand name Desrem in India and will be available to patients later this month
Gilead Sciences to start trials of inhaled version of remdesivir
The FDA granted remdesivir an emergency use authorisation for the treatment of hospitalised patients with severe Covid-19
India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir
The approval process for remdesivir was accelerated in view of emergency situation and unmet need for medicines in light of covid19 outbreak
1 of 1